Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Banco Santander (SAN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Brooks Automation to Present at the Jefferies Global Healthcare Conference

CHELMSFORD, Mass. , May 24, 2018 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq: BRKS) announced today that the company will present at the Jefferies Global Healthcare Conference in New York City. ...

SC : 19.96 (-2.20%)
SAN : 6.01 (-0.83%)
BRKS : 31.19 (+1.96%)
Mahesh Aditya Named Chief Risk Officer of Santander Holdings USA, Inc.

Santander Holdings USA (SHUSA) today announced that its Board of Directors has appointed Mahesh Aditya to serve as the company's Chief Risk Officer (CRO). Aditya, who joined Santander in March 2017 as...

SC : 19.96 (-2.20%)
SAN : 6.01 (-0.83%)
FDA to review Zynquista(TM) (sotagliflozin) as potential treatment for type 1 diabetes

The U.S. Food and Drug Administration (FDA) has accepted Sanofi's regulatory filing for Zynquista (sotagliflozin). The investigational oral treatment would be used in addition to insulin therapy to improve...

SAN : 6.01 (-0.83%)
LXRX : 9.41 (-1.67%)
SNY : 38.64 (+0.08%)
FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes

BRIDGEWATER, N.J. and THE WOODLANDS, Texas , May 22, 2018 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has accepted Sanofi's regulatory...

SAN : 6.01 (-0.83%)
LXRX : 9.41 (-1.67%)
SNY : 38.64 (+0.08%)
New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent® (dupilumab) improved moderate-to-severe asthma

The New England Journal of Medicine (NEJM) today published detailed results from two Phase 3 trials for the investigational use of Dupixent® (dupilumab) in moderate-to-severe asthma. The results showed...

SAN : 6.01 (-0.83%)
REGN : 294.61 (-0.24%)
SNY : 38.64 (+0.08%)
New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent® (dupilumab) improved moderate-to-severe asthma

SAN : 6.01 (-0.83%)
REGN : 294.61 (-0.24%)
SNY : 38.64 (+0.08%)
Breakfast Technical Briefing on Banco Santander and Three Other Banking Stocks

Stock Research Monitor: LYG, RBS, and UBS

SAN : 6.01 (-0.83%)
Santander and Broadridge Complete a First Practical Use of Blockchain for Investor Voting at an Annual General Meeting

MADRID and LAKE SUCCESS, N.Y. , May 17, 2018 /PRNewswire/ --  Banco Santander, S.A. (BME:SAN) and Broadridge Financial Solutions, Inc. (NYSE:BR), a global fintech leader, have completed...

BR : 116.25 (+0.19%)
SAN : 6.01 (-0.83%)
Santander and Broadridge Complete a First Practical Use of Blockchain for Investor Voting at an Annual General Meeting

Banco Santander, S.A. (BME:SAN) and Broadridge Financial Solutions, Inc. (NYSE:BR), a global fintech leader, have completed a first practical use of blockchain for investor voting at an annual general...

BR : 116.25 (+0.19%)
SAN : 6.01 (-0.83%)
NTRS : 107.53 (-0.30%)
Santander Bank Celebrates National Small Business Week by Donating Close to $1.1 Million to Leading Non-Profits Driving Small Business Development

Santander Bank today announced the donation of nearly $1.1 million in grants to more than 16 mission-driven non-profit organizations throughout its footprint that support small business development and...

SAN : 6.01 (-0.83%)
Santander Universities extends partnership with Columbia Business School by providing generous financial support to two entrepreneurship programs

Columbia Business School announced today that Santander Universities has pledged more than $850,000 to support the training and development of entrepreneurs in Latin America and New York City. The funding...

SAN : 6.01 (-0.83%)
Santander Universities extends partnership with Columbia Business School by providing generous financial support to two entrepreneurship programs

NEW YORK , May 1, 2018 /PRNewswire/ -- Columbia Business School announced today that Santander Universities has pledged more than $850,000 to support the training and development of entrepreneurs...

SAN : 6.01 (-0.83%)
Sanofi and Regeneron to lower net price of Praluent® (alirocumab) Injection in exchange for straightforward, more affordable patient access for Express Scripts patients

BRIDGEWATER, N.J. and TARRYTOWN, N.Y. and ST. LOUIS , May 1, 2018 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) and Regeneron Pharmaceuticals, Inc. today announced they will lower the...

SAN : 6.01 (-0.83%)
REGN : 294.61 (-0.24%)
SNY : 38.64 (+0.08%)
Santander Earns an Upgraded Community Reinvestment Act (CRA) Rating from the OCC

Santander Bank, N.A. today announced that it has earned an upgraded Community Reinvestment Act (CRA) overall rating of "Satisfactory" from the Office of the Comptroller of the Currency (OCC) for the 2014...

SC : 19.96 (-2.20%)
SAN : 6.01 (-0.83%)
Santander Earns an Upgraded Community Reinvestment Act (CRA) Rating from the OCC

BOSTON , April 30, 2018 /PRNewswire/ -- Santander Bank , N.A. today announced that it has earned an upgraded Community Reinvestment Act (CRA) overall rating of "Satisfactory" from the Office...

SC : 19.96 (-2.20%)
SAN : 6.01 (-0.83%)
FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma

PARIS and TARRYTOWN, N.Y. , April 30, 2018 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for cemiplimab...

SAN : 6.01 (-0.83%)
REGN : 294.61 (-0.24%)
SNY : 38.64 (+0.08%)
Santander Bank Wins Internet Advertising Award for its Business Banking Microsite

Santander Bank's content-driven website Business First has earned three 2018 Internet Advertising Competition Awards from the Web Marketing Association (WMA) for 'Best Bank Website, Best Financial Services...

SAN : 6.01 (-0.83%)
FDA accepts for review Supplemental Biologics License Application for 0.5 mL dose of Fluzone® Quadrivalent (Influenza Vaccine) in children 6-35 months of age

SWIFTWATER, Pa. , April 25, 2018 /PRNewswire/ -- The U.S. Food and Drug Administration has accepted for review a supplemental Biologics License Application to expand the age indication of the 0.5...

SAN : 6.01 (-0.83%)
SNY : 38.64 (+0.08%)
FDA accepts for review Supplemental Biologics License Application for 0.5 mL dose of Fluzone® Quadrivalent (Influenza Vaccine) in children 6-35 months of age

The U.S. Food and Drug Administration has accepted for review a supplemental Biologics License Application to expand the age indication of the 0.5 mL dose of Sanofi Pasteur's Fluzone® Quadrivalent (Influenza...

SAN : 6.01 (-0.83%)
SNY : 38.64 (+0.08%)
Sanofi to invest ?350 million in Canadian vaccine facility

Sanofi to invest €350 million in Canadian vaccine facility

SAN : 6.01 (-0.83%)
SNY : 38.64 (+0.08%)

Van Meerten Stock Picks

5 Great Growth Stocks
This morning I wanted to find 5 stocks that were predicted to have double digit growth in both Revenue and Earnings over the next 5 years that were also having great current performance.
LULU +1.14 , ABMD -1.06 , AAXN +2.28 , NSP +0.90 , ERI +1.00
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Brugler Ag Report

Today's Commentary

Corn futures were weak into the close on Thursday, down 3 to 4 1/4 cents lower in the front months. Traders were taking money off the table ahead of the extended weekend. The USDA reported a private cancelation of 132,000 of grain sorghum to unknown ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar